PINK:OTLC

Oncotelic Therapeutics Stock Insider Trading

etoro logo Buy OTLC
*Your capital is at risk
$0.0500
+0 (+0%)
At Close: Jun 03, 2026

Oncotelic Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 251.52M and sold 52.51K OTLC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 251.52M shares
Sell 52.51K shares
92% Buy Activity
Weak Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jan 22, 2026
Buy
Series A Convertible Preferred Stock
A-Award
Trieu Vuong
Chairman And CEO
CEO / President 4 426
Value: $339
Nov 17, 2025
Buy
Series A Convertible Preferred Stock
A-Award
Trieu Vuong
Chairman And CEO
CEO / President 4 065
Value: $386
Jul 10, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 104 000
Value: $520
Jul 10, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 104 000
Value: $520
Jul 09, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 1
Value: $0
Jul 09, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 1
Value: $0
Jul 08, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 94 736
Value: $474
Jul 08, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 94 736
Value: $474
Jan 31, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 63 775
Value: $2K
Jan 31, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 63 775
Value: $2K
Jan 30, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 100 003
Value: $3K
Jan 30, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 100 003
Value: $3K
Jan 29, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 183 066
Value: $5K
Jan 29, 2025
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 183 066
Value: $5K
Nov 22, 2024
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 298 499
Value: $9K
Nov 22, 2024
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 298 499
Value: $9K
Aug 23, 2024
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 500 000
Value: $10.0K
Aug 23, 2024
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 500 000
Value: $10.0K
Jun 29, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 425 000
Value: $9K
Jun 29, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 425 000
Value: $9K
Jun 28, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 75 000
Value: $2K
Jun 28, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 75 000
Value: $2K
Jun 16, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 100 000
Value: $3K
Jun 16, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 100 000
Value: $3K
Jun 14, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 400 000
Value: $13.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ONCOTELIC THERAPEUTICS, INC.
Oncotelic Therapeutics
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops O...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE